KLINISCHE FARMACOLOGIE - ALGEMEEN
|
|
|
- Sophia Montgomery
- 8 years ago
- Views:
Transcription
1 PROGRAMMA WETENSCHAPPELIJKE MEDEDELINGENDAG Maandag 2 oktober 2000 DE BLIJE WERELT, LUNTEREN KLINISCHE FARMACOLOGIE - ALGEMEEN VOORDRACHTEN uur D.A.M.C. van de Vijver, R.A.C. Roos, P.A.F. Jansen, A.J. Porsius, A. de Boer (Utrecht): Use of antidepressants in Parkinson s disease; association with disease and its course uur I. Schillevoort, E.P. van Puijenbroek, A. de Boer, R.A.C. Roos, P.A.F. Jansen, H.G.M. Leufkens (Utrecht): Extrapyramidal syndromes associated with SSRI-use uur P.M. Edelbroek, T.A.C. Vermeij, G.J.F. Brekelmans, R.M.Chr. Debets, H.H. Geesink, M.V. Rademaker (Heemstede): Therapeutic drug monitoring of antiepileptic drugs in blood spots dried on filter paper uur A.K. Teeuwisse, A.D. Lindemans, W.M.M. Verschuren, O.H. Klungel, A.J. Porsius, A. de Boer (Utrecht): Undertreatment of hypercholesterolemia in a population-based study in The Netherlands uur M.M.R. de Maat, S.V. Frankfort, R.A.A. Mathôt, J.W. Mulder, P.L. Meenhorst, E.C.M. van Gorp, J.H. Beijnen, A. de Boer, R.M.W. Hoetelmans (Amsterdam): Discrepancies between drug notations in medical records and public pharmacy records in a HIV-1-infected population: a potential for drug-drug interactions uur A.I. Veldkamp, R.P.G. van Heeswijk, J.W. Mulder, P.L. Meenhorst, G. Schreij, S. van der Geest, J.H. Beijnen, J.M.A. Lange, R.M.W. Hoetelmans (Amsterdam): The steady-state pharmacokinetics of saquinavir (SQV-SGC, Fortovase TM ) 1,000 mg bid in combination with ritonavir (RIT) 100 mg bid in HIV-1-infected individuals after a normal and a high-fat breakfast
2 uur C.A.J. Knibbe, K.P. Zuideveld, J. DeJongh, P.F.M. Kuks, L.P.H.J. Aarts, M. Danhof (Nieuwegein): Population pharmacokinetic and pharmacodynamic modelling of Propofol 6% and Propofol 1% for long term sedation in critically ill patients uur E.J. van den Berg, G.J. van der Wilt, C.F.M. Meulendijks, H. Droogleever-Fortuyn, R.J. Verkes, C. Kramers (Nijmegen): Autointoxication patients: who need to be admitted and how long should the observation period be to make this decision? uur D.J.W. van Kraaij, E.J. Vollaard, M. de Metz, A. Witterland (Maastricht): A comparison of the effects of Nabumetone versus Meloxicam on serum thromboxane B2 and platelet function uur KOFFIEPAUZE CARDIOVASCULAIRE FARMACOLOGIE VOORDRACHTEN uur W.M.C. Mulder, S. de Klerk, J.J. Settels, K.H. Wesseling, C.J. van Boxtel (Amsterdam): Clockwise hysteresis of some concentration-cardiovascular effect relationships of terbutaline in man uur M.A. van Baak, G.Hul, S. Toubro, A. Astrup, K.M. Gottesdiener, M. DeSmet, W.H.M. Saris (Maastricht): Acute thermogenic effect of L , a novel beta 3 -adrenoceptor agonist, in obese men uur J.N.J.M. de Hoon, J. Troost, L.M.A.B. van Bortel, H.A.J. Struijker-Boudier (Maastricht): Selective 5-HT 1B/1D receptor agonistinduced peripheral vascular changes in migraine patients uur F.A.A. van Acker, W.M.P.B. Menge, G.R.M.M. Haenen, A. Bast, W.J.F. van der Vijgh (Amsterdam): Frederine, a new synthetic flavonoid, is a promising protector against doxorubicin-induced cardiotoxicity uur H. Bos, R.H. Henning, P.E. de Jong, D. de Zeeuw, G.J. Navis (Groningen): Cholesterol modulates antiproteinuric response of ACEinhibition in experimental nephrosis uur C. Sand, M. Pfaffendorf, P.A. van Zwieten (Amsterdam): The pharmacological activity of therapeutics with antioxidant properties after exposure to electrolysis-induced oxidative stress uur LUNCH
3 POSTERPRESENTATIES uur T.J. Cleophas, B.M. van Ouwerkerk, J. van der Meulen, A.H. Zwinderman, R. van Marum (Dordrecht): Hypertensive patients with diabetes mellitus type II inadequately controlled by angiotensin converting enzyme inhibitors: is the combination with long-acting calcium channel blockers more effective than with beta-blockers? uur S. Gschwend, H. Buikema, Y.M. Pinto, D. de Zeeuw, M. Paul, R. Kreutz, W.H. van Gilst (Groningen): Coronary endothelial dysfunction in hypertensive rats with albuminuria uur A.C.H. Teisman, H. Buikema, D.J. van Veldhuisen, W.H. van Gilst, D. de Zeeuw (Groningen): Dietary sodium restriction improves the effects of ACE-inhibition on ventricular remodeling after myocardial infarction in rats uur J.C. Balt, M.-J. Mathy, M. Pfaffendorf, P.A. van Zwieten (Amsterdam): Blockade of pre- and postsynaptically located AT 1 - receptors; a comparison between valsartan, candesartan, eprosartan and embusartan uur POSTERBEZICHTIGING ALGEMEEN K.P. Zuideveld, P.H. van der Graaf, M. Danhof (Leiden): Allometric scaling of pharmacodynamic responses from rat to man application to the 5-HT 1A receptor mediated hypothermic response H.E. Wiersma, M. Benninga, J.J. Butter, T. Omari, C.J. van Boxtel (Amsterdam): Pharmacokinetics of baclofen in pediatric patients with gastro-oesophageal reflux disease M.A.I. Abou El Hassan, M.A. Kedde, T.H.U. Zwiers, A. Bast, W.J.F. van der Vijgh (Amsterdam): Pharmacokinetics of doxorubicin and monoher in plasma and heart tissue of mice after single and combined administration B.I. Florea, K. Kooiman, K. Derijckere, C. Meany, G. Borchard, H.E. Junginger (Leiden): Elucidation of the transport mechanism of the glucocorticoid Flunisolide in an in vitro Calu-3 cell model for the treatment of asthma J.J.H.M. Lohman (Sittard): Evidence-based guidelines for the treatment of migraine attacks using a combination of a prokinetic antiemetic and an analgesic drug J.P.T. Span, G.F.F.M. Pieters, C.G.J. Sweep, A.R.M.M. Hermus, A.G.H. Smals (Nijmegen): Gender difference in IGF1 response to growth hormone treatment in growth hormone deficient adults; role of sex hormone replacement
4 L.K. van Rossum, K. Cransberg, F. Derkx, J. Lindemans, Y.B. de Rijke, R. Zietse, A.G. Vulto (Rotterdam): The result of determination of the GFR in children by the inulin single-injection method is computer software dependent T.J. Cleophas, R. van Marum (Dordrecht): Efficacy and safety of second generation dihydropyridine calcium channel blockers in heart failure, meta-analysis FARMACOKINETIEK EN TRANSPORT VOORDRACHTEN uur L.J.J. Derijks, L.G.J.B. Engels, P.M. Hooymans, J.J.H.M. Lohman (Sittard): Pharmacokinetics of 6-mercaptopurine and azathioprine in patients with inflammatory bowel disease uur J.J. van der Wildt, C. Neef (Enschede): The pineal gland as infusion system, a pharmacokinetic approach to melatonin uur M. Verschraagen, E. Boven, R. Ruijter, M. Westerman, F.H. Hausheer, W.J.F. van der Vijgh (Amsterdam): Pharmacokinetics of (hydrated)cisplatin and (di)mesna during a phase I study of BNP7787 and cisplatin in cancer patients uur M.P. Schaddelee, D. Groenendaal, L.H. Voorwinden, A.P. IJzerman, A.G. de Boer, M. Danhof (Leiden): Blood-brain barrier transport of adenosine A 1 receptor agonists POSTERPRESENTATIES uur P-H.M. van der Kuy, F.W.H.M. Merkus, F.G.M. Russel, J.J.H.M. Lohman, P.M. Hooymans (Roermond): Pharmacokinetics of intranasal and oral hydroxocobalamin in healthy subjects uur S.A. Terlouw, P.H.H. van den Broek, F.G.M. Russel, R. Masereeuw (Nijmegen): Human colon adenocarcinoma, Caco-2, cells as a tool to study multidrug resistance protein 2-mediated drug secretion uur R. Masereeuw, A.C. Wouterse, S. Notenboom, S.A. Terlouw, F.G.M. Russel (Nijmegen): Impaired renal secretion of substrates for the multidrug resistance protein 2 in mutant transport deficient (TR - ) rats uur J.M.K. van Fessem, I.C.J. van der Sandt, E.C.M. de Lange, A.G. de Boer, D.D. Breimer (Leiden): Loss of integrity of the blood-brain barrier by vinblastine after inhibition of P-glycoprotein function
5 uur I.C.J. van der Sandt, R. Smolders, L. Nabulsi, K.P. Zuideveld, A.G. de Boer, D.D. Breimer (Leiden): Active transport of the 5- HT 1A receptor agonist flesinoxan by P-glycoprotein across the blood-brain barrier uur BEKENDMAKING WINNAAR NVKF&B-PROEFSCHRIFTPRIJS 2000 HUISHOUDELIJKE VERGADERING
6 This document was created with Win2PDF available at The unregistered version of Win2PDF is for evaluation or non-commercial use only.
Small artery tone under control of the endothelium
Small artery tone under control of the endothelium On the importance of EDHF and myogenic tone in organ (dys)function Simone K. Gschwend Publication of this thesis was supported by generous contributions
BSc in Medical Sciences with PHARMACOLOGY
BSc in Medical Sciences with PHARMACOLOGY Course Director Dr Christopher John Module Leaders Dr Robert Dickinson (Module 1) Dr Anabel Varela Carver (Module 2) Dr Sohag Saleh (Module 3) Course Administrator
Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital
Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI
Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology
Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology The chart below lists the measures (and specialty exclusions) that eligible providers must demonstrate
PROGRAMMA WETENSCHAPPELIJKE MEDEDELINGENDAG Vrijdag 16 april 2004 Jaarbeursgebouw, Utrecht
PROGRAMMA WETENSCHAPPELIJKE MEDEDELINGENDAG Vrijdag 16 april 2004 Jaarbeursgebouw, Utrecht 09.00 uur ONTVANGST VOORDRACHTEN 09.30 uur F.W. Asselbergs, G.F.H. Diercks, H.L. Hillege, A.J. van Boven, W.M.T.
HYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
Drug Treatment in Type 2 Diabetes with Hypertension
Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk
Radiology Business Management Association Technology Task Force. Sample Request for Proposal
Technology Task Force Sample Request for Proposal This document has been created by the RBMA s Technology Task Force as a guideline for use by RBMA members working with potential suppliers of Electronic
Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW
Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)
Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012
Psychiatrists and Reporting on Meaningful Use Stage 1 August 6, 2012 Quick Overview Functional Measures Providers (tracked by NPI) must report on 15 core objectives and associated measures and 5 objectives
Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis
Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly
ACLS PHARMACOLOGY 2011 Guidelines
ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.
Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration
Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Hiddo Lambers Heerspink Department of Clinical Pharmacology University Medical
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized
Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary. http://www.cms.gov/ehrincentiveprograms/
Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary 2010 What are the Requirements of Stage 1 Meaningful Use? Basic Overview of Stage 1 Meaningful Use: Reporting period
Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene
Stage 1 Meaningful Use for Specialists NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene 1 Today s Agenda Meaningful Use Overview Meaningful Use Measures Resources Primary
Can Common Blood Pressure Medications Cause Diabetes?
Can Common Blood Pressure Medications Cause Diabetes? By Nieske Zabriskie, ND High blood pressure, or hypertension, is a major risk factor for cardiovascular disease. In the United States, approximately
Milwaukee School of Engineering Gerrits@msoe.edu. Case Study: Factors that Affect Blood Pressure Instructor Version
Case Study: Factors that Affect Blood Pressure Instructor Version Goal This activity (case study and its associated questions) is designed to be a student-centered learning activity relating to the factors
Nursing 113. Pharmacology Principles
Nursing 113 Pharmacology Principles 1. The study of how drugs enter the body, reach the site of action, and are removed from the body is called a. pharmacotherapeutics b. pharmacology c. pharmacodynamics
ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.
Mededelingendag Vrijdag 21 april 2006. Nederlandse Vereniging voor Klinische Farmacologie en Biofarmacie
Mededelingendag Vrijdag 21 april 2006 Nederlandse Vereniging voor Klinische Farmacologie en Biofarmacie PROGRAMMA WETENSCHAPPELIJKE MEDEDELINGENDAG Vrijdag 21 april 2006 Jaarbeursgebouw, Utrecht De Nederlandse
Guidelines for the management of hypertension in patients with diabetes mellitus
Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes
CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
PROGRAMME of the SCIENTIFIC MEETING Tuesday October 4, 2005 Congress Hotel De Werelt, Lunteren
PROGRAMME of the SCIENTIFIC MEETING Tuesday October 4, 2005 Congress Hotel De Werelt, Lunteren 08.30 h REGISTRATION AND COFFEE 09.00 h SCIENTIFIC MEETING OF THE DUTCH SOCIETY FOR CLINICAL PHARMACOLOGY
Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
2012 Physician Quality Reporting System:
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services R Official CMS Information for Medicare Fee-For-Service Providers 2012 Physician Quality : Medicare Electronic Health Record
Manitoba EMR Data Extract Specifications
MANITOBA HEALTH Manitoba Data Specifications Version 1 Updated: August 14, 2013 1 Introduction The purpose of this document 1 is to describe the data to be included in the Manitoba Data, including the
Primary Care Quality Care Indicators - Accuro EMR Prevention
Quality Indicators Primary Care Quality Care Indicators - Accuro EMR Prevention Data needs to be entered as indicated in order to auto populate the worksheet Date of colon cancer screening Exemption from
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
Vascular Effects of Caffeine
Vascular Effects of Caffeine John P. Higgins MD, MBA, MPHIL, FACC, FACP, FAHA, FACSM, FASNC, FSGC Director of Exercise Physiology Memorial Hermann Sports Medicine Institute Chief of Cardiology, Lyndon
Microalbuminuria: An increasingly recognized risk factor for CVD
Microalbuminuria: An increasingly recognized risk factor for CVD Long known to be associated with kidney disease, the importance of protein in the urine is now becoming recognized as a sensitive, accessible
ONWAR. 9th GRADUATE COURSE ON NEUROPSYCHOPHARMACOLOGY SEPTEMBER 3-10, 2015
ONWAR 9th GRADUATE COURSE ON NEUROPSYCHOPHARMACOLOGY SEPTEMBER 3-10, 2015 1 PREFACE This 9 th graduate Neuropsychopharmacology course, designed for PhD students and postdocs in the field of neurosciences,
Cardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
High Blood pressure and chronic kidney disease
High Blood pressure and chronic kidney disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney
Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
trends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223-
Review Article Pharmacological trends in the treatment of Diabetes type 2 - New classes of antidiabetic Silvia Mihailova 1*, Antoaneta Tsvetkova 1, Anna Todorova 2 1 Assistant Pharmacist, Education and
Stage 2 June 13, 2014
Stage 2 June 13, 2014 1 General Overview of Idaho Medicaid s EHR Incentive Program Stage 2 Meaningful Use (MU) Overview 2014 Reporting Helpful Resources 2 3 Medicaid can pay certain providers an incentive
CASE B1. Newly Diagnosed T2DM in Patient with Prior MI
Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic
Overview of Clinical Quality Measures Reporting in the Centers for Medicare & Medicaid Services (CMS) Final Rule on Meaningful Use
Overview of Clinical Quality Measures Reporting in the Centers for Medicare & Medicaid Services (CMS) Final Rule on Meaningful Use Clinical Quality Measures Clinical quality measures have been defined
PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT
DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT Diabetic nephropathy affects people with either type 1 or type 2 diabetes mellitus.
a Phase 2 prostate cancer clinical trial is ongoing. Table 2: Squalamine vs Standard-of-care literature
PRODUCT FACT SHEET Spring 2007 MISSION STATEMENT Genaera Corporation is a biopharmaceutical company with a focus on metabolic and respiratory diseases. The compounds in the Genaera pipeline address signal
Public Assessment Report. Decentralised Procedure
Public Assessment Report Decentralised Procedure TELMISARTAN DR REDDY S 20 MG TABLETS TELMISARTAN DR REDDY S 40 MG TABLETS TELMISARTAN DR REDDY S 80 MG TABLETS (telmisartan) Procedure No: UK/H/5034/001-003/DC
Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours
Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours Presented by New York State Council of Health system Pharmacists October 18 19, 2013 St. John s University,
Case Study 6: Management of Hypertension
Case Study 6: Management of Hypertension 2000 Scenario Mr Ellis is a fit 61-year-old, semi-retired market gardener. He is a moderate (10/day) smoker with minimal alcohol intake and there are no other cardiovascular
New Anticoagulants: When and Why Should I Use Them? Disclosures
Winship Cancer Institute of Emory University New Anticoagulants: When and Why Should I Use Them? Christine L. Kempton, MD, MSc Associate Professor of Pediatrics and Hematology and Medical Oncology Hemophilia
Scientific Spring Meeting Friday March 30, 2012
Scientific Spring Meeting Friday March 30, 2012 Dutch Society for Clinical Pharmacology and Biopharmacy Nederlandse Vereniging voor Klinische Farmacologie en Biofarmacie PROGRAMME of the SCIENTIFIC MEETING
EFFIMET 1000 XR Metformin Hydrochloride extended release tablet
BRAND NAME: Effimet XR. THERAPEUTIC CATEGORY: Anti-Diabetic PHARMACOLOGIC CLASS: Biguanides EFFIMET 1000 XR Metformin Hydrochloride extended release tablet COMPOSITION AND PRESENTATION Composition Each
OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION
OBJECTIVES Kimberly S. Hodge, PhDc, MSN, RN, ACNS-BC, CCRN- K Director, ACO Care Management & Clinical Nurse Specialist Franciscan ACO, Inc. Central Indiana Region Indianapolis, IN By the end of this session
嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs MEDICARE FACT SHEET FOR IMMEDIATE RELEASE
DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
MEASURING CARE QUALITY
MEASURING CARE QUALITY Region November 2015 For Clinical Effectiveness of Care Measures of Performance From: Healthcare Effectiveness Data and Information Set (HEDIS ) HEDIS is a set of standardized performance
The Association of Vitamin D Dietary Intake and Type 2 Diabetes Among African Americans in Central Ohio
The Association of Vitamin D Dietary Intake and Type 2 Diabetes Among African Americans in Central Ohio Presenter: Sin Nee Ng Advisors: Dr. Julie Kennel, Dr. Tonya Orchard Copyright 2014 Sin Nee Ng. All
Chapter 28. Drug Treatment of Parkinson s Disease
Chapter 28 Drug Treatment of Parkinson s Disease 1. Introduction Parkinsonism Tremors hands and head develop involuntary movements when at rest; pin rolling sign (finger and thumb) Muscle rigidity arthritis
Endocrine Responses to Resistance Exercise
chapter 3 Endocrine Responses to Resistance Exercise Chapter Objectives Understand basic concepts of endocrinology. Explain the physiological roles of anabolic hormones. Describe hormonal responses to
EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS
EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS Steven T. Johnson, PhD 1 Introduction The prevalence of chronic diseases like cardiovascular
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary
High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4
High Blood Pressure and Chronic Kidney Disease For People With CKD Stages 1 4 National Kidney Foundation s Kidney Disease Outcomes Quality Initiative (NKF-KDOQI ) The National Kidney Foundation s Kidney
Medicare & Medicaid EHR Incentive Programs. Specifics of the Program for Eligible Professionals
Medicare & Medicaid EHR Incentive Programs Specifics of the Program for Eligible Professionals Today s Session This training will cover the following topics: EHR Incentive Programs a Background Who Is
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME
1 University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL SEMINAR INSULIN RESISTANCE, POLYCYSTIC OVARIAN
Improving Quality of Care for Medicare Patients: Accountable Care Organizations
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Improving Quality of Care for Medicare Patients: FACT SHEET Overview http://www.cms.gov/sharedsavingsprogram On October
4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH
METABOLIC SYNDROME AN INTEGRATIVE APPROACH AN OPPORTUNITY FOR PHARMACISTS TO MAKE A DIFFERENCE Mike Rizo, Pharm D, MBA, ABAAHP THE EVOLUTION OF THE PHARMACIST 1920s 1960s 2000s THE PHARMACIST OF THE FUTURE?
Adrenergic agonists. R. A. Nimmi Dilsha Department of pharmacy Faculty of Health Sciences The Open University of Sri Lanka
Adrenergic agonists R. A. Nimmi Dilsha Department of pharmacy Faculty of Health Sciences The Open University of Sri Lanka Outline Recall Introduction to adrenergic agonists Classification of adrenergic
About High Blood Pressure
About High Blood Pressure Your Treatment & You: working together to help manage your health Glaxo- Blood Pressure Booklet (ASK) EN.indd 1 10/7/2014 4:49:14 PM Glaxo- Blood Pressure Booklet (ASK) EN.indd
Hypertension and Heart Failure Medications. Dr William Dooley
Hypertension and Heart Failure Medications Dr William Dooley Plan Heart Failure Acute vs. chronic Mx Hypertension Common drugs used Method of action Choice of medications Heart Failure Aims; Short term:
HEdis Code Quick Reference Guide Disease Management Services
HEdis Code Quick Reference Guide Disease Management Services Respiratory Conditions Appropriate Testing for Children With Pharyngitis (ages 2-18) [Commercial, Medicaid] Appropriate Treatment (no antibiotic)
FACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN
FACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN General Pantarhei Bioscience B.V. is an emerging specialty pharmaceutical company with a creative approach towards drug development. The Company
2013 ACO Quality Measures
ACO 1-7 Patient Satisfaction Survey Consumer Assessment of HealthCare Providers Survey (CAHPS) 1. Getting Timely Care, Appointments, Information 2. How well Your Providers Communicate 3. Patient Rating
High Blood Pressure and Your Kidneys
High Blood Pressure and Your Kidneys About 65 million Americans have high blood pressure, but as many as one third or three in 10 don't even know it. There are usually no signs or symptoms that your blood
Diabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
ECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
Chronic Kidney Disease and Diabetes
Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by
We're Ready for MU2...Are You?
Meaningful Use Are you considering purchasing an Electronic Health Record (EHR) or moving from your current vendor? Is your goal to attain Meaningful Use status in order to receive EHR incentive dollars?
Aligning Incentives for Quality: Pharmacy's Role in Achieving Hospital and National Goals. Objectives. National Organizations: Key Linkages
Aligning Incentives for Quality: Pharmacy's Role in Achieving Hospital and National Goals Kasey K. Thompson, Pharm.D. Director, Practice Standards and Quality Division Director, Patient Safety American
Pharmacology of the Respiratory Tract: COPD and Steroids
Pharmacology of the Respiratory Tract: COPD and Steroids Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart
Pharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System
Pharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. What
In many diabetes units, people with type
Renal Microalbuminuria: Screening and management in type 2 diabetes Julia Arundale Introduction In many diabetes units, patients with type 1 or type 2 diabetes are screened for proteinuria. Screening for
GloP1r - A New Frontier in Exercise and Nutrition
Central Florida Research Update Ayala, Julio, PhD, Sanford-Burnham Medical Research Institute, Orlando, Florida Anorectic Mechanisms of Glp1r Agonists Obesity Jan 1, 2014 Dec 31, 2018 Integrated Physiology,
Antiplatelet and Antithrombotics From clinical trials to guidelines
Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories
List of publications
List of publications List of publications List of publications L. van Bloemendaal & J.S. ten Kulve, S.E. la Fleur, R.G. IJzerman, M. Diamant. Effects of glucagonlike peptide 1 on appetite and body weight:
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen
Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical
Hypertension Guideline V4
Hypertension Guideline V4 Approved 24/06/2008 Version VERSION 4 FINAL Date of First Issue 26/02/08 Review Date 01/03/2010 Date of Issue 24/06/2008 EQIA Yes / No 24/06/2008 Author / Contact Dr Leslie Cruickshank
Summary of QOF indicators
Summary of QOF indicators Clinical domain Atrial fibrillation (AF) AF001. The contractor establishes and maintains a register of patients with atrial fibrillation AF002. The percentage of patients with
Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8)
Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) Adapted by Capital Health Plan Approved by Quality Improvement
Hypertension Guidelines
Overview Hypertension Guidelines Aim to reduce Blood Pressure to 140/90 or less (140/80 for diabetics), adding drugs as needed until further treatment is inappropriate or declined. N.B. patients do not
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
Orchard Software Webinar August 19, 2010. Slide 1
Slide 1 An Update on ARRA and Its Impact on Laboratories Presented By: Curt Johnson VP of Sales & Marketing cjohnson@orchardsoft.com www.orchardsoft.com (800) 856-1948 Orchard Software Webinar August 19,
High Blood Pressure and Chronic Kidney Disease
High Blood Pressure and Chronic Kidney Disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney
Medicare EHR Incentive Program - Meaningful Use
EHR Incentive Programs A program administered by the Centers for Medicare & Medicaid Services (CMS) An Introduction to the Medicare EHR Incentive Program for Eligible Professionals cms.gov/ehrincentiveprograms
Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims
Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research
Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae
Ariela Benigni Biol.Sci.D., Ph.D. Curriculum Vitae Personal Data Name: Date and place of birth: Citizenship: E-mail: Ariela Benigni December 16, 1955 - Bergamo, Italy Italian ariela.benigni@marionegri.it
Medication Utilization. Understanding Potential Medication Problems of the Elderly
Medication Utilization Understanding Potential Medication Problems of the Elderly NICE - National Initiative for the Care of the Elderly WHAT ARE MEDICATION UTILIZATION PROBLEMS AMONG THE ELDERLY? A useful
Dorset Cardiac Centre
P a g e 1 Dorset Cardiac Centre Patients with Atrial Fibrillation/Flutter undergoing DC Cardioversion or Ablation procedures- Guidelines for Novel Oral Anti-coagulants (NOACS) licensed for this use February
Correspondence to: Rima B Shah (rima_1223@yahoo.co.in) DOI: 10.5455/ijmsph.2013.2.167-172 Received Date: 29.11.2012 Accepted Date: 03.12.
RESEARCH ARTICLE STUDY OF UTILIZATION PATTERN OF ANTI-HYPERTENSIVE DRUGS IN HYPERTENSIVE DIABETIC PATIENTS WITH OR WITHOUT REDUCED RENAL FUNCTION AT TERTIARY CARE TEACHING HOSPITAL Jay Shah 1, Tejas Khakhkhar
Male Health. The three major issues are: Cardiovascular Health Prostate Health Fertility & Sexual Performance
Male Health Do Men Value Their Health? The ancient Greek physician Hippocrates once said, A wise man ought to realise that his health is his most valuable possession. It is believed that Hippocrates lived
Getting the most from blood pressure medicines
P R E S S U R E P O I N T S S E R I E S : NO. 4 Getting the most from blood pressure medicines B L O O D P R E S S U R E A S S O C I AT I O N Pressure Points series Pressure Points is a series of booklets